Published April 07, 2022 By Alex Keown BioSpace Jazz Pharmaceuticals continues to advance its efforts toward becoming a leading oncology company via a key licensing deal with Werewolf Therapeutics for […]
https://www.pharmalive.com/wp-content/uploads/2022/01/Jazz-Pharmaceuticals-Lays-Out-Vision-2025-BioSpace-1-14-22.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-04-07 11:51:302022-04-07 12:51:44Jazz howls at immuno-oncology success with Werewolf alliance